ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men
- PMID: 35250987
- PMCID: PMC8892378
- DOI: 10.3389/fimmu.2022.812940
ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the current coronavirus disease 2019 (COVID-19) pandemic, affecting more than 219 countries and causing the death of more than 5 million people worldwide. The genetic background represents a factor that predisposes the way the host responds to SARS-CoV-2 infection. In this sense, genetic variants of ACE and ACE2 could explain the observed interindividual variability to COVID-19 outcomes. In order to improve the understanding of how genetic variants of ACE and ACE2 are involved in the severity of COVID-19, we included a total of 481 individuals who showed clinical manifestations of COVID-19 and were diagnosed by reverse transcription PCR (RT-PCR). Genomic DNA was extracted from peripheral blood and saliva samples. ACE insertion/deletion polymorphism was evaluated by the high-resolution melting method; ACE single-nucleotide polymorphism (SNP) (rs4344) and ACE2 SNPs (rs2285666 and rs2074192) were genotyped using TaqMan probes. We assessed the association of ACE and ACE2 polymorphisms with disease severity using logistic regression analysis adjusted by age, sex, hypertension, type 2 diabetes, and obesity. The severity of the illness in our study population was divided as 31% mild, 26% severe, and 43% critical illness; additionally, 18% of individuals died, of whom 54% were male. Our results showed in the codominant model a contribution of ACE2 gene rs2285666 T/T genotype to critical outcome [odds ratio (OR) = 1.83; 95%CI = 1.01-3.29; p = 0.04] and to require oxygen supplementation (OR = 1.76; 95%CI = 1.01-3.04; p = 0.04), in addition to a strong association of the T allele of this variant to develop critical illness in male individuals (OR = 1.81; 95%CI = 1.10-2.98; p = 0.02). We suggest that the T allele of rs2285666 represents a risk factor for severe and critical outcomes of COVID-19, especially for men, regardless of age, hypertension, obesity, and type 2 diabetes.
Keywords: ACE; ACE2; COVID-19; SARS-CoV-2; genetic variants; polymorphism.
Copyright © 2022 Martínez-Gómez, Herrera-López, Martinez-Armenta, Ortega-Peña, Camacho-Rea, Suarez-Ahedo, Vázquez-Cárdenas, Vargas-Alarcón, Rojas-Velasco, Fragoso, Vidal-Vázquez, Ramírez-Hinojosa, Rodríguez-Sánchez, Barrón-Díaz, Moreno, Martínez-Ruiz, Zayago-Angeles, Mata-Miranda, Vázquez-Zapién, Martínez-Cuazitl, Barajas-Galicia, Bustamante-Silva, Zazueta-Arroyo, Rodríguez-Pérez, Hernández-González, Coronado-Zarco, Lucas-Tenorio, Franco-Cendejas, López-Jácome, Vázquez-Juárez, Magaña, Cruz-Ramos, Granados, Hernández-Doño, Delgado-Saldivar, Ramos-Tavera, Coronado-Zarco, Guajardo-Salinas, Muñoz-Valle, Pineda, Martínez-Nava and López-Reyes.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.J Med Virol. 2021 Oct;93(10):5947-5952. doi: 10.1002/jmv.27160. Epub 2021 Jul 10. J Med Virol. 2021. PMID: 34170561 Free PMC article.
-
Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.PLoS One. 2022 Feb 4;17(2):e0263140. doi: 10.1371/journal.pone.0263140. eCollection 2022. PLoS One. 2022. PMID: 35120165 Free PMC article.
-
SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease.Virol J. 2022 Mar 19;19(1):48. doi: 10.1186/s12985-022-01782-6. Virol J. 2022. PMID: 35305693 Free PMC article.
-
Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis.Microb Pathog. 2022 Nov;172:105781. doi: 10.1016/j.micpath.2022.105781. Epub 2022 Sep 15. Microb Pathog. 2022. PMID: 36116608 Free PMC article.
-
Single Nucleotide Variants (SNVs) of Angiotensin-Converting Enzymes (ACE1 and ACE2): A Plausible Explanation for the Global Variation in COVID-19 Prevalence.J Renin Angiotensin Aldosterone Syst. 2023 Apr 3;2023:9668008. doi: 10.1155/2023/9668008. eCollection 2023. J Renin Angiotensin Aldosterone Syst. 2023. PMID: 37051471 Free PMC article. Review.
Cited by
-
Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key.Front Immunol. 2022 Aug 22;13:973070. doi: 10.3389/fimmu.2022.973070. eCollection 2022. Front Immunol. 2022. PMID: 36072602 Free PMC article. Review.
-
Canadian COVID-19 host genetics cohort replicates known severity associations.PLoS Genet. 2024 Mar 22;20(3):e1011192. doi: 10.1371/journal.pgen.1011192. eCollection 2024 Mar. PLoS Genet. 2024. PMID: 38517939 Free PMC article.
-
Are COVID-19 Polymorphisms in ACE and ACE2 Prognosis Predictors?Curr Issues Mol Biol. 2024 Jul 28;46(8):8111-8117. doi: 10.3390/cimb46080480. Curr Issues Mol Biol. 2024. PMID: 39194697 Free PMC article.
-
Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry.Microbiol Spectr. 2025 Aug 5;13(8):e0324424. doi: 10.1128/spectrum.03244-24. Epub 2025 Jun 20. Microbiol Spectr. 2025. PMID: 40539804 Free PMC article.
-
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis.Viruses. 2023 Aug 12;15(8):1724. doi: 10.3390/v15081724. Viruses. 2023. PMID: 37632067 Free PMC article. Review.
References
-
- WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int (Accessed January 21, 2021).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous